About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2][3] - The news team covers key finance and investing hubs, focusing on medium and small-cap markets, as well as blue-chip companies and broader investment stories [2][3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3][4] Group 2 - The company utilizes technology to enhance workflows and has a team with decades of expertise [3] - Proactive employs automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [4]

Core Insights - The antiviral market is projected to reach USD 74.75 billion by 2028, with nanotechnology companies aiming to capture significant market share [2] - NanoViricides, Inc. is developing NV-387, a broad-spectrum antiviral drug that shows promise against multiple viruses, including coronaviruses and RSV [3][11] - The need for effective antiviral treatments, particularly for COVID-19, is highlighted by the ongoing challenges posed by new variants [4][9] Company Developments - NanoViricides has completed a Phase 1 safety study for NV-387, with results expected in the second half of 2024, and is planning a Phase 2 trial for RSV [3][9] - NV-387 has demonstrated a 180% improvement in survival rates in animal studies compared to Remdesivir, indicating its potential effectiveness [6] - The company is seeking collaborations with pharmaceutical firms to expedite regulatory approvals for NV-387 across multiple antiviral indications [17] Market Context - The current antiviral landscape is dominated by limited options, with Paxlovid being the only oral drug available for COVID-19, which has shown weak clinical effectiveness [8][12] - The global market opportunity for RSV vaccines is substantial, potentially reaching USD 9 billion to 10 billion, indicating a growing demand for innovative antiviral solutions [14] - Major pharmaceutical companies are diversifying their pipelines to address various viral threats, with Moderna recently receiving FDA approval for an RSV vaccine [15][16]

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...

Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research Read more Proactive has always been a forward looking and enthusiastic technology adopter. About this content About the publisher Proactive news team spans the world's key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. The team delivers news and unique insights across the market including but not co ...

About Oliver Haill Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists. The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies. ...

Group 1 - Proactive is a forward-looking company that embraces technology and automation, including generative AI, while ensuring all content is edited and authored by humans [2][5]. - The company operates a global network with bureaus and studios in major financial hubs such as London, New York, Toronto, Vancouver, Sydney, and Perth [4]. - Proactive's editorial team produces a significant volume of content, creating approximately 50,000 pieces of news, feature articles, and filmed interviews annually [3]. Group 2 - The financial news and online broadcast teams at Proactive focus on delivering fast, accessible, and actionable business and finance news to a global investment audience [6]. - Proactive covers a wide range of sectors, including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [7]. - The company’s content creators possess extensive expertise and experience, utilizing technology to enhance their workflows [8].

Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The Canberra Times, and... Read more Abou ...

Core Insights - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience, focusing on medium and small-cap markets as well as blue-chip companies and broader investment stories [1][2]. Group 1: Company Overview - Proactive has a global presence with bureaus and studios located in major finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2]. - The company specializes in delivering news and unique insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3]. Group 2: Technology Adoption - Proactive is committed to adopting technology to enhance its content creation and workflow processes, utilizing decades of expertise from its human content creators [4]. - The company occasionally employs automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans to maintain quality and best practices in content production [5].

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...